Maximum quantity allowed is 999
Please select the quantity
CAS RN: 104344-23-2 | Product Number: B3994
Bisoprolol Hemifumarate
×
![]()
×
Purity: >98.0%(T)(HPLC)
Synonyms:
Product Documents:
| Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time |
Shipping Information
|
|---|---|---|---|---|---|
| 200MG |
$133.00
|
29 | 0 | Contact Us |
* Please contact our distributors or
TCI
to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
* The storage conditions are subject to change without notice.
| Product Number | B3994 |
| Purity / Analysis Method | >98.0%(T)(HPLC) |
| Molecular Formula / Molecular Weight | C__1__8H__3__1NO__4·^^1/__2C__4H__4O__4 = 383.49 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
| Packaging and Container | 200MG-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 104344-23-2 |
| Related CAS RN | 66722-44-9 |
| Reaxys Registry Number | 6049645 |
| PubChem Substance ID | 160871433 |
| Merck Index (14) | 1295 |
| MDL Number | MFCD00792743 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | min. 98.0 % |
| Melting point | 101.0 to 105.0 °C |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 102 °C |
| Solubility (soluble in) | Ethanol |
| Solubility (insoluble in) | Ether |
GHS
| Pictogram |
|
| Signal Word | Warning |
| Hazard Statements | H302 : Harmful if swallowed. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
Related Laws:
| RTECS# | UB8390000 |
Transport Information:
| H.S.code* | 2922.50-000 |
Application
Studies of beta-Adrenoceptor Antagonists
References
- Tissue distribution of basic drugs: Accounting for enantiomeric, compound and regional differences amongst beta-blocking drugs in rat
- The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors
- Comparative pharmacology of human beta-adrenergic receptor subtypes-characterization of stably transfected receptors in CHO cells
- Constitutive activity of the human beta1-adrenergic receptor in beta1-receptor transgenic mice
- S. Engelhardt, Y. Grimmer, G.-H. Fan, M. J. Lohse, Mol. Pharmacol. 2001, 60, 712.
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.